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doi:10.1016/j.ejvs.2008.11.001Abstract Up to 40% of abdominal aortic aneurysms have co-existing unilateral or bilateral
iliac artery ectasia or aneurysm. These are associated with an increased risk of endoleak,
morbidity and mortality following endoluminal repair. To reduce the adverse sequelae of
internal iliac artery (IIA) occlusion, various open, endovascular and hybrid measures have been
described to maintain perfusion to the pelvis. This review discusses the contemporary manage-
ment of aorto-iliac aneurysm in the endovascular era with reference to the sequelae of IIA
occlusion and the strategies to preserve IIA perfusion. Particular consideration is given to iliac
bifurcation devices.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The 17 years that have followed Parodi’s pioneering
endoaneurysmorraphy have witnessed numerous refine-
ments in endograft technology. The development of
modular stent graft systems has afforded the versatility to
treat a broader array of abdominal aortic aneurysm (AAA)
morphologies.1 The general applicability of endovascular
aneurysm repair (EVAR) continues to be constrained by
hostile anatomy,2 difficult access3 and aneurysmal exten-
sion into the iliac arteries.(0)161 2768525; fax: þ44
ac.com (J. Ghosh).
ty for Vascular Surgery. PublisheAlthough isolated iliac aneurysms are uncommon with
a prevalence of 0.008e0.03%,4 up to 40% of AAA have co-
existing unilateral or bilateral iliac artery ectasia or aneu-
rysm.5,6 Aorto-iliac aneurysm poses particular challenges to
the vascular specialist when compared to isolated aortic
aneurysm. The EUROSTAR experience has shown concomi-
tant aortic and iliac aneurysms to be associated with an
increased prevalence of cardiac, renal and respiratory
comorbidity, in addition to more complex anatomy.6
Furthermore, EVAR of aorto-iliac aneurysms using conven-
tional endografts was found to be associated with a greater
incidence of type I endoleak, secondary interventions and
delayed rupture.
Internal iliac artery (IIA) embolisation or coverage due to
absence of a suitable common iliac artery landing zone is now
a common necessity. For example, in a large single-centred by Elsevier Ltd. All rights reserved.
Endovascular Era 183experience, intentional IIA occlusion was required in 26% of
all aortic endografts (24% unilateral and 2% bilateral).7 It has
become well recognised that unilateral and bilateral IIA
occlusions are associated with variable risks of complica-
tions, including: buttock or thigh claudication, sexual
dysfunction, colonic ischaemia, perineal necrosis, non-
healing pressure sores, paraesthesia and incontinence and
acute limb ischaemia.8,9 Notable factors that promote pelvic
ischaemic complications following IIA occlusion include
greater than 70% stenosis at the origin of the contralateral
IIA, absence of filling of three or more named IIA branches,
and diseased or absent ascending branches from the ipsilat-
eral common femoral artery.7
To reduce the adverse sequelae of IIA occlusion, various
open, endovascular and hybrid measures have been
described to maintain perfusion to the pelvis. This article
reviews the contemporary management of aorto-iliac
aneurysm in the endovascular era. A review of the sequelae
of unilateral and bilateral IIA occlusions is presented. The
hybrid and endovascular stratagems for IIA preservation are
then discussed with special consideration given to iliac
bifurcation devices (IBDs).Sequelae of Unilateral and Bilateral Internal
Iliac Artery Occlusions
An assertion held by many vascular specialists is that
unilateral IIA occlusion carries a lower incidence of
ischaemic complications than bilateral. Over a dozen
studies have contrasted the sequelae of unilateral and
bilateral IIA occlusions in reference to buttock/thigh clau-
dication and erectile dysfunction. These data have been
reviewed by Rayt et al. who compared 29 patients who had
undergone either unilateral or bilateral IIA occlusions with
the published literature.10 The authors found no significant
differences in claudication rates following unilateral and
bilateral IIA occlusion. In 11 papers detailing follow up of
301 patients undergoing unilateral IIA occlusion, 29%
developed buttock claudication and 18% sexual dysfunc-
tion. In comparison, eight series following up a total of 90
patients after bilateral IIA occlusion found incidences of
post-procedural buttock claudication and sexual dysfunc-
tion to be 32% and 18%. No statistically significant differ-
ence was shown between unilateral and bilateral IIA
occlusions. Similarly, a series of 39 patients undergoing
bilateral IIA embolisation prior to EVAR found post-proce-
dural buttock claudication in 31% of patients, falling to 9%
after one year. Sexual dysfunction was only seen in 5% and
spinal ischaemia in 3%.11 There did not appear to be any
clinical advantage in performing sequential over simulta-
neous IIA embolisation with a view to promote collateral
vessel development.
Interpretation of these data is constrained by small
numbers within most individual series, subjectivity in
patient assessment and heterogeneity in follow up. Also,
the aetiology and assessment of sexual dysfunction may be
difficult given the common confounding co-morbidities of
diabetes mellitus, prostate surgery, renal failure and
advanced age. Nevertheless, the published evidence is
counter to the commonly held belief that more adverse
outcomes may be expected with bilateral IIA sacrifice.Sequelae of Internal Iliac Artery Non-
Embolisation
Evidence is now emerging that challenges the traditional
paradigm of IIA embolisation prior to EVAR for aorto-iliac
aneurysm. A retrospective analysis of 11 EVARs that had
been preceded by unsuccessful IIA embolisation found no
endoleaks.12 It is hypothesized that the complex iliac
anatomy precluding IIA intubation in these patients
protects against back bleeding into the aneurysm sac.
These data harmonise with other small series where IIA
embolisation was not performed and the ostium covered
either by a bridging stent through which the EVAR endograft
is deployed,13 or by the stent graft itself.14 Though it would
be precipitate to conclude that IIA embolisation is unnec-
essary, inaccessibility of the IIA should not be viewed as an
absolute contraindication to aorto-iliac EVAR.
The question of whether IIA coverage or coil embolisation
results in worse pelvic ischaemia or increased endoleak was
addressed in a single-centre experience of 147 patients
requiring occlusion of one or both IIA (67 coil embolisations,
80 coverage by stent graft limb).15 At six months there was
a significantly higher incidence of buttock ischaemia
following embolisation compared to IIA ostium coverage (42%
Versus 8%). Incidence of sexual dysfunction and endoleak
was however unchanged. Similar findings were found by
Wyers et al., who demonstrated buttock claudication in 27%
of patients undergoing IIA coverage versus 45% of those
undergoing embolisation.14 Left ventricular dysfunction and
young age were found particular risk factors for buttock
claudication. It is hypothesized that embolisation within the
IIA disturbs collateralisation, resulting in persisting
ischaemia, which is more symptomatic in the more active,
less comorbid patient. Whether this may be attenuated by
very proximal placement of embolisation coils in the IIA is not
ascertainable from the data, though others have noted
reduced complications with coil deployment into the main IIA
trunk compared to more distally.11 These data support
a policy of selective IIA embolisation when deployment into
the external iliac artery is necessitated.
Methods of IIA Preservation Following EVAR
Hybrid open and endovascular procedures
Early stratagems for IIA preservation relied on a combined
open surgery and endovascular approach. Relocation of the
IIA origin was first proposed by Parodi and Ferreira.16 This
technique entails deployment of a bifurcated endograft
into the external iliac artery (EIA), thereby covering the IIA
ostium (Fig. 1a). The IIA is isolated, ligated proximally to
prevent backflow into the iliac aneurysm and a bridging
graft sutured from the common femoral or EIA to the IIA
remnant. This technique is disadvantaged by the need for
significant retroperitoneal exposure and risk of venous,
ureteric and collateral vessel injury. Though effective in
preserving flow, IIA repositioning detracts from the mini-
mally invasive nature of EVAR with a potential increase in
morbidity and recovery time.
The Reverse-U stent graft described by Kotsis et al.17 is
another, more complex, stratagem for maintaining IIA
Figure 1 (a) Relocation of origin of internal iliac arteries. (b) The Reverse-U stent graft: (1) Stent from EIA to IAA; (2) Embo-
lisation of contralateral IIA; (3) Aorto-uniiliac stent graft; (4) Femoro-femoral crossover graft. (c) Bifurcated stent graft:
(1) Embolisation of ipsilateral IIA; (2) bifurcated stent graft with extension into ipsilateral EIA and contralateral IIA; (3) Femoro-
femoral crossover graft and; (4) ligation of contralateral EIA.
184 J. Ghosh et al.perfusion (Fig. 1b). This technique entails deployment of an
aorto-uniiliac stent graft after initial IIA embolisation, to
exclude the aorto-iliac aneurysm. A contralateral EIA to IIA
stent graft is deployed and flow to the contralateral limb is
restored using a femoro-femoral crossover graft. Similar
methods had been described prior to this report to manage
iliac aneurysms. Hoffer et al. first described use of
a specially modified covered EIA to IIA stent to exclude
a common iliac artery aneurysm.18 This was followed a year
later by Derom et al., who used a Haemobahn endograft
(W.L. Gore & associates) as an ‘off-the-shelf’ EIA to IIA
conduit to repair a bilateral common iliac aneurysm after
an open aortic aneurysm repair.19 Clarke et al. used
a Wallgraft (Boston Scientific) to same effect.20 The EIA to
IIA shunt allows pelvic perfusion through retrograde flowFigure 2 (a) Helical Branch Device. (b): ZBIS Device (Images cou
EVAR (Arrow highlights iliac side branch).from the femoro-femoral graft. Drawbacks of this tech-
nique are the prolonged operating, contrast and X-ray
times, and the reliance on retrograde flow to the contra-
lateral leg and pelvis.
Another hybrid open/endovascular procedure described
is by Delle et al.21 Following embolisation of the ipsilateral
IIA, an Excluder (W.L. Gore & associates) endograft main
body deployed in the EIA via the femoral route. Through
a brachial approach, the patent contralateral IIA is cannu-
lated. A covered stent graft is then deployed into the patent
IIA to exclude the aneurysm sac (Fig. 1c). The now unper-
fused EIA is then ligated to avert backflow into the aneurysm
sac, and a femoro-femoral crossover graft fashioned to
restore flow down both legs. Though perfusion to the IIA is
more anatomic, flowing in an antegrade rather thanrtesy of Cook Medical, UK). (c): Fully deployed ZBIS enhanced
Endovascular Era 185retrograde manner, this procedure is constrained in a similar
manner to the Reverse-U graft. For both techniques, signif-
icant concerns exist with reference to the dependency upon
the aorto-uniiliac graft and femoro-femoral cross-over graft
as conduits for pelvic and lower limb perfusion; thrombotic
or infective complications of either component would lead
to devastating consequences for the patient.
Endovascular methods
Hybrid open and endovascular techniques to preserve IIA
perfusion diminish the advantages bestowed by the mini-
mally invasive nature of EVAR. A ‘bell-bottomed’ configu-
ration to EVAR iliac extension limbs have been proposed to
allow aneurysm sac exclusion in the presence of challenging
iliac anatomy without recourse to open surgery. Though
such endograft extensions have enjoyed success in some
aneurysm morphologies,22 the maximal 24 mm diameter
confines their use to small iliac aneurysms or ectasia. More
recently, iliac branch devices (IBDs) have been utilised as
a purely endovascular solution to preserving IIA flow.
Iliac branch devices
An IBD is an endograft iliac extension limb that is charac-
terised by a short side branch that is used to perfuse the
IIA. The IBD is deployed in conjunction with the main body
of an aortic stent graft to exclude the aorto-iliac aneurysm.
IBDs preserve IIA perfusion, whilst preserving the benefits
of minimally invasive endoluminal surgery.
IBDs have evolved over the last decade, which has seen
this concept being integrated into single body23 and
modular24,25 configurations. Success of early designs was
constrained by stent graft dislocation or kinking, leading to
thrombosis and endoleaks at the junction of the side branch
and bridging stent graft. Contemporary IBD configurations
derive from the design of Chuter and colleagues,25 who
constructed a bifurcated iliac component by amputating
the proximal two stents from a Cook Zenith AAA endograft
main body. Presently there are two IBD designs in usage;
these are the Helical Branch Endograft (HBE) and the Zenith
Bifurcated Iliac Side (ZBIS) branch devices (Fig. 2a and b).
Over a thousand of such devices have now been deployed
(personal communication Cook Medical UK) and both areTable 1 IBD series patient and operative details
Authors No of centres No of patients
Dias et al.32 2 23
Ziegler et al.29 1 46
Serracino-Inglott et al.26 1 8
Haulon et al.31 6 52
Age Median AAA
diameter (mm)
Mean C
diame
Dias et al. 70 (65e79) 52 (37e60) 34 (27
Ziegler et al. 68.6 (52e86) 57.1 11.2 32.3
Serracino-Inglott et al. 72.1 (64e80) 48 (20e60) 31.5 (1
Haulon et al. 72 (56e86) 56 (32e89) 38 (23based upon the Cook Zenith platform and used in
conjunction with a standard Zenith Flex main body. The
HBE (Fig. 2a) designed by Greenberg and colleagues
consists of a 12 mm stent graft that extends from the origin
of the common iliac artery to the EIA to which an 8 mm
tubular branch is anastomosed in a beveled manner. The
internal iliac branch length is 29.3 mm in length and runs
longitudinally and circumferentially around the 12 mm
tubular graft, terminating 150 degrees away from the
proximal anastomosis. The device is configured with a left-
or right-hand orientations and the long side branch length
maximizes overlap with the bridging stent into the IIA.
Unlike the ZBIS, the HBE is of a fixed length and sizing is not
required. The HBE design aims to maintain rotational ability
and to be capable of addressing angulation between the
external and internal iliac artery origins in large common
iliac artery aneurysms.
The ZBIS (Fig. 2b, c) resembles a standard Zenith limb
extension but has a side branch attached to its body
approximately half way down. To accommodate an IBD the
target common iliac artery must have a diameter of at least
20 mm. The stiff ZBIS side branch is designed to facilitate
IIA cannulation and protect against collapse and kinking
which would result in side branch occlusion. In the USA the
ZBIS and HBE devices have approval for investigational use
only. Both ZBIS and HBE devices are recipients of a CE mark
for marketing within the European Union. Further detailed
descriptions of these devices are available elsewhere.26,27
The price differential between IBD and conventional EVAR
using the Zenith platform is £3000 (approx. $6000;
personal communication Cook Medical, UK) plus the addi-
tional cost of the bridging stent. This should be taken into
context with the overall pricing of EVAR compared to open
surgery,28 when economic issues are under consideration.
Accurate planning for an IBD enhanced EVAR necessi-
tates high-resolution CT imaging with a maximum of 3 mm
slices and 3 planar reconstructions. It is recommended that
the target CIA should have a length of at least 50 mm and
minimal diameter of 20 mm adjacent to the branch, In
addition to these considerations, a wide aortic bifurcation,
minimal IIA tortuosity and a long IIA landing zone are
favorable anatomic factors. Twenty-French femoral access
should be available but the operator should also beDevice used Median Follow up (range) months
2 in-house 20 (8e31)
18 ZBIS
3 HBE
26 1st generation 24 (3e60)
20 ZBIS
ZBIS 6 (1e14)
Helical 14 (e)
IAA
ter (mm)
Median Op
time (min)
Iodine
usage (g)
Median Inpatient
stay (d)
e41) 279 (234e327) 58 (48e78) 4 (3e6)
10.1 183 (100e330) 88 (35e180) 4 (2e44)
.5e6.3) 101 (84e130) 101 (84e130) 4 (3e5)
e78) e 208 e
Table 2 Indications for surgery in individual IBD series
(by percent)
Secondary
procedure
AAAþ
CIAAA
Solitary
CIAA
IIIA
Dias et al. 4.3 60.7 35
Ziegler et al. 8.7 73.9 17.4
Serracino-Inglott et al. 12.5 75 12.5
Haulon et al. 80 20
(UICAAZ unilateral common iliac aneurysm; BCIAAZ bilateral
common iliac aneurysm; IIIAZ internal iliac artery aneurysm).
186 J. Ghosh et al.prepared to establish endovascular access from above.
Excessive vessel tortuosity may compromise flow beyond
the iliac bifurcation and make IBD delivery, orientation,
rotation and cannulation difficult.
Evidence for IBDs
To date there have been three published single-centre26,27,29
and two multi-centre30e32 series for IBD usage. Since the
Greenberg/Haulon27,31 and Malina/Dias30,32 series have
short and medium term follow up data for the same pop-
ulations published in separate papers, only the most recent
data from each centre are considered for the purpose of this
review.
The particulars of each series including aneurysm
morphology, operative details and indications for EVAR are
summarised in Tables 1 and 2. Taken together these series
embody a total 129 patients. Haulon et al.31, in the largest
series, employed the Helical device. Dias et al.32 primarily
used the ZBIS in 18 cases, the HBE in 3 and in two cases an
‘in-house’ custom made endograft based on the Chuter
design. Ziegler et al.29 in a series of 46 used a now dis-
continued unibody design IBD for their first 26 patients,
followed by the modular ZBIS in the final 20. Serracino-
Inglott et al.26 used the ZBIS in all eight patients. Aneurysm
morphology in the Haulon et al. series is not fully eluci-
dated, although 80% had bilateral common iliac arteryTable 3 Outcomes of individual IBD series
Dias et al. Haulon et al.
n 23 52
Intra-op 2 failures:
2 branch occln
(1 ZBIS, 1 HBE)
3 failures:
2 unable to visualise IIA
1 unable to cross aortic bifurca
30 day 1 Death (MI)
1 TIA
1 branch occln
6 IIA occln
2 EIA thrombosis
11 type 2 endoleak
Late 1 Death (MI) 1 type 2 endoleak
1 Type 3 endoleak
3 branch occln
Overall
Mortality
2 7
(MI) (6 MI, 1 intracerebral haemo
MI: Myocardial infarction; occln: occlusion; IMA: inferior mesenteric aaneurysm, 7.7% had iliac aneurysms with aortic diameters
<5 cm, and at least 4% had undergone previous aortic
reconstruction. In this series, it is noteworthy that 33% had
the IBD deployed in conjunction with a fenestrated or
branched main body.
Outcomes for individual series and pooled data are
summarised in Tables 3 and 4. In all series, there were no
instances of post procedure buttock/thigh claudication or
pelvic/hindgut ischaemia in the presence of a patent IBD.
The Haulon series does not elaborate upon total operating
time, although mean fluoroscopy time was 64 min. Adjust-
ing for the Haulon series, the mean overall operative time
was 187 min. Intraoperative deployment failure occurred in
16.3% of cases, although 11.3% were accounted for by first
generation devices. In the Ziegler and Haulon series
thrombolysis and angioplasty were used successfully to
treat thrombosis. Inability to cannulate IIA was managed by
coverage of the side branch by a limb extension. Within
30 days of surgery, 8.5% of cases were discovered to have
endoleaks, predominantly type II, and 7% of side branches
were occluded. After 30 days, a further 7.8% of side
branches became occluded and another 1.5% developed
type II endoleaks, and IIA aneurysm formation was seen in
a single patient (0.8%). One patient in the Dias series was
found to have a type III endoleak at the junction of the IBD
and main aortic endograft which was treated using an
extension cuff. Overall mortality was 7%, with no aneurysm
related deaths. The majority of deaths were reported in
the series by Haulon et al., in which a third of patients had
the IBD deployed in conjunction with a fenestrated main
body endograft. Though such procedures are technically
more challenging than conventional EVAR to a higher
complication profile, it is not stated whether these patients
were related with the reported mortality. Not included in
this review is a more recent two patient case series
reporting the successful treatment of common iliac artery
aneurysms using IBDs following previous open infrarenal
aortic aneurysm repair.33 Neither patient had evidence of
endoleak nor occlusion at ten-month follow up, although itZiegler et al. Serracino-Inglott et al.
46 8
tion
16 failures (13 1st
generation device):
2 device
8 cannulation
1 side branch
deployment failure
5 intraoperative occln
0
0 1 IIA occln
4 branch occln 1 type 2 endoleak (IMA)
2 groin lymphoceles
0 0
rrhage)
rtery; TIA: transient ischaemic attack.
Table 4 Pooled outcome data from all IBD series
n (%)
Patients 129
Optimum time (m) 187 (100e330)
Median inpatient stay (d) 4 (2e44)
Intraoperative failure 21 16.3
<30 d complications 10 IIA/EIA occlusions 7.7
1 TIA 0.7
11 Type 2 endoleak 8.5
>30 d complications 7 Occlusions 5.4
3 Type 2 endoleak 2.3
1 Type 3 endoleak 0.7
Mortality 9 7
Endovascular Era 187is not indicated whether there were symptoms of pelvic
ischaemia. Comparison between the published series high-
lights no clear advantages for either ZBIS or HBE device. As
experience with these devices increases, the relative
merits of each device in different aneurysm morphologies
are likely to become elucidated.
Conclusion
The traditional endovascular treatment for aorto-iliac
aneurysm entails IIA embolisation and landing the stent
graft in the EIA. Contrary to popular perception, intentional
unilateral IIA occlusion appears to carry a similar risk of
symptoms as bilateral, ranging from 9e45%. However, the
natural history of these sequelae remains unclear and there
is a paucity of data defining the incidence of severe
complications following bilateral compared to unilateral IIA
occlusion. The role of hybrid open and endovascular tech-
niques to maintain IIA patency can be questioned as they
diminish the minimally invasive advantages of EVAR.
IBDs represent a significant advance in the endovascular
management of aorto-iliac aneurysms. Deployment failures
were predominantly issues with earlier generation devices,
and with increased experience of contemporary IBDs we
expect the incidence of intraoperative failures to further
diminish. Long-term follow up data and larger series will
further delineate the safety and efficacy of this device. It is
the authors’ practice to consider IBD enhanced EVAR as
a first line treatment in selected patients, in whom the risks
of symptomatic pelvic ischaemia would constitute a signifi-
cant impairment to daily function.
Disclosure
Mr. Serracino-Inglott and Dr. Farquharson are European
proctors for Cook Medical.
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